RxDoctor Payments Data

Todd Shaffer, PA

Physician Assistant · Columbus, OHNPI 1538124417

Payments from drug & device makers

$1,329in general payments, 2019–2025

Across 37 payments — averaging $35.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$455
  • Abbott$182
  • Novartis$147
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$147
  • Impulse Dynamics (USA) Inc.$126
  • Medtronic$123
  • plus $150 from 3 others

What the payments were for

  • Food & beverage$1,04178%
  • Education$28822%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,329 in reported general payments places this provider in the 80th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$44,610
Medicare patients
368
Services billed
715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban326$300,661
EntrestoSacubitril/Valsartan49$52,492
XareltoRivaroxaban49$51,713
BrilintaTicagrelor29$16,193
MultaqDronedarone Hcl15$12,296
FarxigaDapagliflozin Propanediol13$11,309
Ranolazine ErRanolazine29$4,292
Metoprolol Succinate325$4,258
Atorvastatin Calcium258$3,996
Diltiazem 24hr Er (Cd)Diltiazem Hcl52$1,521
Isosorbide Mononitrate ErIsosorbide Mononitrate88$1,214
Amiodarone Hcl24$1,142
Carvedilol140$1,142
Losartan Potassium94$1,091
ClopidogrelClopidogrel Bisulfate113$1,073

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$23$300,661326 claims
NovartisEntresto$147$52,49249 claims
AstraZenecaBrilinta, Farxiga$455$27,50342 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →